OncLive | Bringing the Global Oncology Community Together

A new drug application has been submitted to Japan's Ministry of Health, Labor and Welfare for quizartinib for the treatment of adult patients with FLT3-ITD–positive acute myeloid leukemia. Read More >>

SOSS GI USC 2018: Optimal Sequencing Key Next Step for HCC Paradigm

SOSS GI USC 2018: Expert Discusses Emerging Treatments in Early Pancreatic Cancer

SOSS GI USC 2018: Lenz Highlights Ongoing Advances in mCRC

FDA Grants Priority Review to Ibrutinib Plus Obinutuzumab in Frontline CLL

FDA Grants Olaparib Orphan Drug Designation for Pancreatic Cancer

View More Stories >>

View Conference Coverage

2018 State of the Science Summit on Hematologic Malignancies in Clayton

State of the Science Summit on GI Cancers in Newport Beach

2018 ESMO Congress

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

2018 Lynn Sage Breast Cancer Symposium

Dr. Villaruz on EGFR-Targeted Therapies in NSCLC

Dr. Gradishar on Personalized Treatment in Breast Cancer

Dr. Lenz on Breakthrough Designation of Encorafenib, Binimetinib, and Cetuximab in BRAF+ CRC

Cosmo Smith on The Breakthrough Oncology Accelerator Flagship Program

Dr. El-Khoueiry Discusses Recent Combination Data in HCC

Dr. Leighl Discusses Binimetinib in KRAS-Mutated NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Osimertinib's Role in EGFR+ Metastatic Lung Cancer

Managing Oligometastases With Ablative Therapy in NSCLC

CheckMate 227: TMB Versus PD-L1 in Advanced-Stage NSCLC

Treatment After Progression in Advanced-Stage NSCLC

Personal Use of I-O Therapy in Advanced-Stage NSCLC

Advanced-Stage NSCLC: KEYNOTE-189's Role in Treatment

Appropriate Settings for the PACIFIC Regimen in NSCLC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Management of Metastatic Colorectal Cancer

Emerging Therapy in Metastatic Colorectal Cancer

BEACON Trial: Triplet Therapy in BRAF V600E

Moving the AML Treatment Landscape Forward

Optimizing the Use of FLT3 Inhibitor Therapy for AML

Long-Term Challenges With FLT3 Inhibition in AML

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>